Triple-negative breast cancer is a particularly aggressive form of the disease with no specific treatment. In a new study led by the University of Pennsylvania’s Rumela Chakrabarti, researchers discovered that, in contrast to many other cancer types, activation of the interferon gamma signaling contributes to disease progression and spread. The findings may help doctors choose a personalized treatment strategy for triple-negative breast cancer patients, depending on their cancer subtype.
- For black girls, attitudes about being black affect risk of depression
- “New” lactic acid bacteria can make African camel milk safe
- County and ZIP code-level data show ‘stark social inequities’ in COVID-19
- Entomologists from SPbU discover a rare species of tropical Heteroptera with long antennae
- Wild birds as offerings to the Egyptian gods